Ashwagandha is one of the most popular supplements for thyroid support, and the clinical evidence for subclinical hypothyroidism is genuinely promising. The Sharma et al. 2018 RCT showed significant TSH, T3, and T4 improvement at 600mg daily over 8 weeks. But this study did not include Hashimoto's patients — and that distinction changes everything.
Hashimoto's thyroiditis accounts for 90% of hypothyroidism in the developed world. If you are hypothyroid, there is a high probability the cause is autoimmune. Stimulating a thyroid gland that is under active immune attack creates a fundamentally different risk profile than stimulating a healthy-but-underperforming gland.
This article breaks down when ashwagandha helps, when it harms, and how to decide which category you fall into. Discuss all supplementation with your physician before starting.
What Ashwagandha Actually Does in the Body
Ashwagandha (Withania somnifera) is a nightshade-family plant used for millennia in Ayurvedic medicine. Its active compounds, withanolides (primarily withaferin A and withanolide D), are responsible for most of its pharmacological effects.
Adaptogenic Stress Response
Ashwagandha is classified as an adaptogen — a compound that modulates the hypothalamic-pituitary-adrenal (HPA) axis to normalize the body's stress response. The Chandrasekhar et al. 2012 RCT demonstrated a 27.9% reduction in serum cortisol in chronically stressed adults taking 300mg of KSM-66 ashwagandha extract twice daily for 60 days.
This cortisol-lowering effect is relevant to thyroid function because chronic cortisol elevation:
- Suppresses TSH secretion from the pituitary
- Inhibits T4-to-T3 conversion via deiodinase suppression
- Increases reverse T3 (rT3), which blocks T3 receptor binding
- Impairs gut barrier integrity, contributing to immune dysregulation
For the stress-thyroid connection in detail, see our guide on Hashimoto's and stress.
Direct Thyroid Stimulation
Beyond stress modulation, ashwagandha appears to directly stimulate thyroid hormone production. Animal studies reviewed by Gannon et al. 2014 show increased serum T4 and T3 concentrations in both hypothyroid and euthyroid (normal thyroid) animals receiving ashwagandha extract.
The proposed mechanisms include:
- Upregulation of thyroid peroxidase (TPO) activity — the enzyme that synthesizes thyroid hormones
- Enhanced iodine uptake by thyroid follicular cells
- Increased hepatic conversion of T4 to T3 via deiodinase stimulation
- Antioxidant protection of thyroid tissue via withanolide-mediated free radical scavenging
This dual action — HPA axis modulation plus direct thyroid stimulation — is why ashwagandha produces measurable thyroid hormone changes in clinical trials, not just stress reduction.
Immune Modulation
Withanolides have documented immunomodulatory properties. Depending on the context, ashwagandha can:
- Enhance innate immunity — increasing natural killer (NK) cell activity and macrophage function
- Modulate Th1/Th2 balance — which may be beneficial or harmful depending on the direction of existing immune dysregulation
- Reduce NF-kB activation — lowering inflammatory cytokines (IL-6, TNF-alpha)
In a healthy individual or someone with general immune weakness, immune enhancement is desirable. In someone with active autoimmunity — where the immune system is already overactive and attacking self-tissue — immune stimulation can accelerate tissue destruction.
The Evidence FOR Ashwagandha and Thyroid Function
Sharma et al. 2018 — The Key RCT [Grade B]
The most cited clinical trial is the Sharma et al. 2018 randomized, double-blind, placebo-controlled study published in the Journal of Alternative and Complementary Medicine.
Study design:
- 50 adults with subclinical hypothyroidism (elevated TSH 4.5–10 mIU/L, normal T3/T4)
- Exclusion criteria: patients with overt hypothyroidism, thyroid antibodies, or thyroid medication were excluded
- Treatment: 600mg ashwagandha root extract daily for 8 weeks
- Primary endpoints: TSH, T3, T4
Results:
- TSH decreased significantly in the ashwagandha group vs placebo
- Serum T3 increased significantly
- Serum T4 increased significantly (normalized in most subjects)
- No serious adverse events reported
Key finding
Sharma et al. 2018 showed that 600mg/day ashwagandha root extract significantly improved TSH, T3, and T4 in subclinical hypothyroidism over 8 weeks. But this study excluded patients with thyroid antibodies — meaning it tells us nothing about safety or efficacy in Hashimoto's disease.
This is a well-designed trial with meaningful results for non-autoimmune subclinical hypothyroidism. The critical limitation is the antibody exclusion criterion. The study population had sluggish thyroids without an autoimmune component. Extrapolating these results to Hashimoto's is scientifically inappropriate.
Cortisol Reduction and the HPA-Thyroid Axis [Grade B]
The Chandrasekhar et al. 2012 RCT (64 subjects, 60 days) established ashwagandha's cortisol-lowering effect. For individuals whose thyroid dysfunction is driven primarily by chronic stress and HPA axis dysregulation, this mechanism alone may improve thyroid function indirectly.
The pathway: lower cortisol → improved TSH signaling → better T4-to-T3 conversion → reduced rT3 → improved thyroid hormone availability at the tissue level.
This is a real mechanism with clinical relevance, particularly for the subset of hypothyroid patients whose primary driver is stress rather than glandular dysfunction or autoimmunity.
Gannon et al. 2014 — Thyroid-Stimulating Review [Grade C]
Gannon et al. reviewed the preclinical and clinical evidence for ashwagandha's thyroid effects. The review confirmed dose-dependent increases in thyroid hormones in animal models and highlighted the need for larger human trials, particularly in autoimmune thyroid disease.
This review is mechanistic context, not clinical proof. It supports the biological plausibility of ashwagandha's thyroid effects but does not establish safety in Hashimoto's.
The Evidence AGAINST Ashwagandha for Hashimoto's
Most ashwagandha articles stop at the Sharma trial and move on. The evidence against using ashwagandha for Hashimoto's is equally important. The evidence for thyroid stimulation in subclinical hypothyroidism does not translate to a recommendation for Hashimoto's. Here is why.
The Autoimmune Problem: Stimulating a Gland Under Attack
In Hashimoto's thyroiditis, the immune system is producing TPO antibodies and thyroglobulin antibodies that attack and gradually destroy thyroid tissue. The gland cycles between:
- Destruction phases — immune cells destroy thyrocytes, releasing stored thyroid hormones (causing transient hyperthyroid symptoms, known as hashitoxicosis)
- Hypothyroid phases — sufficient tissue has been destroyed that hormone production falls below demand
Ashwagandha stimulates thyroid activity. If you stimulate a gland during a destruction phase, you may:
- Increase the metabolic activity of thyrocytes, making them more visible targets for immune attack
- Amplify hashitoxicosis episodes by adding exogenous stimulation on top of hormone release from tissue destruction
- Accelerate the overall trajectory from subclinical to overt hypothyroidism
This is a theoretical but mechanistically sound concern. No RCT has tested ashwagandha specifically in Hashimoto's patients to confirm or rule this out — which itself is a reason for caution.
Case Reports of Ashwagandha-Induced Thyrotoxicosis
Multiple published case reports document thyrotoxicosis triggered by ashwagandha supplementation:
Kamal et al. 2022 reported a case of ashwagandha-induced thyrotoxicosis in a patient who developed classic hyperthyroid symptoms (tachycardia, tremor, weight loss, elevated free T4, suppressed TSH) after several weeks of ashwagandha supplementation. Symptoms resolved after discontinuation.
Van der Hooft et al. 2005 documented thyrotoxicosis from a herbal preparation containing ashwagandha as the primary thyroid-active ingredient. The patient required beta-blockers to manage symptoms during the resolution period.
Case reports: thyrotoxicosis risk
Published case reports document ashwagandha-induced thyrotoxicosis — a state of excess thyroid hormones causing rapid heart rate, tremor, anxiety, and weight loss. Hashimoto's patients are especially vulnerable because they can swing between hypo- and hyperthyroid states. Adding a thyroid stimulant to this unstable system increases the risk of dangerous episodes.
Case reports are low-level evidence (Grade C) and cannot establish prevalence — but they confirm the mechanism is real, not theoretical.
Ashwagandha Is a Nightshade
Withania somnifera belongs to the Solanaceae (nightshade) family, alongside tomatoes, peppers, potatoes, and eggplant. Nightshades contain alkaloids (solanine, capsaicin, and in ashwagandha's case, withanolides) that some autoimmune patients find trigger symptom flares.
The Autoimmune Protocol (AIP) diet eliminates all nightshades during the elimination phase. If you are following AIP — as many Hashimoto's patients do, particularly those with gut symptoms or high antibodies — ashwagandha is eliminated by default.
This is not a universal problem. Many people tolerate nightshades without issue. But for the subset of autoimmune patients who are nightshade-reactive, ashwagandha can trigger:
- Increased joint pain
- Digestive symptoms (bloating, cramping)
- Skin flares
- General inflammation increase
Immune Stimulation Concerns
As discussed above, ashwagandha enhances certain arms of the immune system, including NK cell activity and macrophage function. In autoimmune disease, the immune system is already dysregulated and overactive against self-tissue.
While ashwagandha also has anti-inflammatory properties (NF-kB inhibition), the net effect on autoimmune disease activity is unpredictable and uncharacterized in clinical trials. No study has measured TPO antibody changes in Hashimoto's patients taking ashwagandha.
This is a data gap, not definitive evidence of harm. But given that safer alternatives with established Hashimoto's evidence exist, the risk-benefit calculation shifts against ashwagandha for this population.
The Critical Distinction: Hashimoto's vs General Hypothyroidism
This is the single most important point in this article, and the one most commonly missed.
| Subclinical Hypothyroidism (Non-Autoimmune) | Hashimoto's Thyroiditis | |
|---|---|---|
| Cause | Sluggish thyroid, iodine issues, aging, medication side effects | Autoimmune destruction of thyroid tissue |
| Antibodies | Absent (TPO-Ab, Tg-Ab negative) | Present (TPO-Ab and/or Tg-Ab positive) |
| Thyroid gland | Intact, underfunctioning | Under active immune attack |
| Risk of thyroid stimulation | Low — stimulating a healthy gland is logical | High — stimulating a gland under attack may worsen destruction |
| Ashwagandha evidence | Sharma 2018 RCT supports benefit | No RCT data; case reports suggest risk |
| Hashitoxicosis risk | None | Real — destruction releases stored hormones |
| Better first-line options | Ashwagandha, iodine (if deficient), selenium | Selenium, myo-inositol, vitamin D |
For a deeper look at how Hashimoto's differs from general hypothyroidism, see our complete Hashimoto's natural treatment guide.
If you do not know whether your hypothyroidism is autoimmune, get TPO and thyroglobulin antibodies tested. This single lab result changes your entire supplement strategy. See optimal lab ranges for Hashimoto's for target values.
Who SHOULD Consider Ashwagandha
Should You Take Ashwagandha? Decision Guide
Follow the flowchart based on your thyroid diagnosis, antibody status, and current protocol.
This is a general guide. Always discuss supplement changes with your healthcare provider, especially if you take thyroid medication.
1. Subclinical Hypothyroidism Without Autoimmune Component
If your TSH is mildly elevated (4.5–10 mIU/L), T3 and T4 are still within range, and TPO and Tg antibodies are negative, you are the population studied in the Sharma 2018 trial. Ashwagandha at 600mg daily for 8 weeks is a reasonable evidence-based intervention.
2. Stress-Driven Thyroid Dysfunction
If your primary issue is chronic stress with secondary thyroid effects (elevated cortisol, mildly elevated TSH, high rT3), ashwagandha's cortisol-lowering properties address the root cause. The Chandrasekhar 2012 RCT supports this use at 300mg KSM-66 twice daily.
This applies whether or not you have Hashimoto's, but if you do have Hashimoto's, the thyroid-stimulating effect is a complicating factor. Rhodiola rosea offers cortisol and stress support without thyroid stimulation and is the safer choice for Hashimoto's patients whose primary goal is stress management.
3. Hashimoto's in Remission — With Strict Conditions
Some Hashimoto's patients in deep remission (TPO antibodies consistently below 35 IU/mL, stable thyroid function for 6+ months, no recent flares) may tolerate ashwagandha under medical supervision. The conditions for a cautious trial:
- Baseline thyroid panel immediately before starting
- Start low: 300mg KSM-66 (not 600mg)
- 8-week trial with clear stopping criteria
- Retest full thyroid panel at 8 weeks
- Stop immediately if any hyperthyroid symptoms appear
Even in this scenario, ashwagandha is not first-line. The interventions with actual Hashimoto's-specific evidence — selenium, myo-inositol, vitamin D — should be established first.
Who Should AVOID Ashwagandha
Graves' Disease — Absolute Contraindication
Ashwagandha is contraindicated in Graves' disease. Graves' is autoimmune hyperthyroidism — the thyroid is already overstimulated by thyroid-stimulating immunoglobulins (TSI). Adding a compound that further stimulates thyroid hormone production is dangerous and can precipitate thyroid storm, a life-threatening emergency.
This is not nuanced. If you have Graves' disease, do not take ashwagandha in any form or dose.
Active Hashimoto's With Elevated Antibodies
If your TPO antibodies are elevated (above 100 IU/mL, and especially above 500 IU/mL), your immune system is actively attacking your thyroid gland. This is not the time to stimulate thyroid activity.
Priority interventions for active Hashimoto's:
- Selenium — 200mcg selenomethionine daily (Grade A for TPO antibody reduction)
- Myo-inositol — 600mg with selenium (Grade B for TSH normalization)
- Vitamin D — optimize to 40–60 ng/mL (Grade B for autoimmune risk reduction)
- AIP elimination diet — address dietary triggers including nightshades
Revisit ashwagandha only after antibodies have stabilized and the immune attack has quieted.
Anyone on Thyroid Medication Without Monitoring
Ashwagandha increases endogenous thyroid hormone production. If you are taking levothyroxine, liothyronine, or natural desiccated thyroid (NDT), adding ashwagandha without dose adjustment and monitoring can push total thyroid hormone levels too high.
Symptoms of overreplacement/excess:
- Rapid or irregular heartbeat (palpitations)
- Anxiety, irritability, insomnia
- Tremor
- Heat intolerance, excessive sweating
- Unexplained weight loss
- Diarrhea
If you take thyroid medication and want to try ashwagandha, your endocrinologist needs to be involved. More frequent thyroid monitoring (every 4–6 weeks initially) is required.
Pregnancy
Ashwagandha is classified as potentially unsafe during pregnancy. High doses have shown abortifacient properties in animal studies. Pregnant women should not take ashwagandha regardless of thyroid status.
Nightshade-Sensitive Individuals
If you have identified nightshade sensitivity through AIP elimination/reintroduction, ashwagandha will trigger the same reactions as tomatoes, peppers, and potatoes. This includes joint inflammation, digestive distress, and skin flares.
Dosing, Forms & Standardization
Standardized Extracts
Not all ashwagandha products are equivalent. The clinical evidence comes from standardized root extracts, not raw root powder.
| Extract | Standardization | Trial Doses | Key Studies |
|---|---|---|---|
| KSM-66 | Full-spectrum root extract, ≥5% withanolides | 300mg twice daily (600mg total) | Chandrasekhar 2012, Sharma 2018 |
| Sensoril | Root + leaf extract, ≥10% withanolide glycosides | 125–250mg twice daily | Auddy et al. 2008 |
| Raw root powder | Unstandardized, variable withanolide content | 1–6g daily (traditional) | No controlled trials |
KSM-66 is the most commonly studied and recommended extract for thyroid applications. The Sharma 2018 RCT that demonstrated thyroid hormone improvement used an ashwagandha root extract at 600mg daily — consistent with KSM-66 dosing protocols.
Dosing Strategy
For thyroid support (non-autoimmune subclinical hypothyroidism):
- 600mg/day KSM-66 ashwagandha root extract
- Take with meals (morning or lunch — ashwagandha can be mildly stimulating)
- 8-week minimum trial before reassessing
For stress and cortisol reduction:
- 300mg KSM-66 twice daily (morning and evening)
- Can be taken with or without food
- Effects on cortisol typically measurable within 30–60 days
For Hashimoto's patients attempting a cautious trial (doctor-supervised only):
- Start at 300mg KSM-66 once daily
- Do not exceed 300mg daily for the first 8 weeks
- Always with baseline and follow-up thyroid panels
What to Avoid
- Products combining ashwagandha with iodine or kelp — the additive thyroid stimulation is unpredictable
- Unstandardized powders or tinctures — inconsistent withanolide content makes dosing unreliable
- High-dose products (1,000mg+ extract per serving) — exceeds the studied range and increases thyrotoxicosis risk
- Any product if you have not confirmed your antibody status — know whether you have Hashimoto's before starting
Better Alternatives for Hashimoto's Patients
If you have confirmed Hashimoto's and want evidence-based thyroid support, these interventions have stronger safety and efficacy data than ashwagandha for your specific condition.
Selenium — Grade A
200mcg selenomethionine daily is the single best-supported supplement for Hashimoto's. The 2024 Huwiler meta-analysis (2,358 patients, 29 cohorts) confirmed significant TPO antibody reduction. Unlike ashwagandha, selenium addresses the autoimmune mechanism directly by supporting glutathione peroxidase, the enzyme that neutralizes the hydrogen peroxide generated during thyroid hormone synthesis.
Full evidence review: Selenium for Hashimoto's
Myo-Inositol — Grade B
600mg myo-inositol with 83mcg selenium (the combination studied by Nordio et al. 2017) improved TSH normalization and antibody reduction beyond selenium alone. This addresses thyroid function and autoimmunity without the thyroid-stimulating risks of ashwagandha.
Full evidence review: Myo-Inositol for Hashimoto's
Rhodiola Rosea — Grade B for Stress
If your primary goal is stress management and cortisol reduction, rhodiola rosea (200–400mg standardized to 3% rosavins) offers adaptogenic stress support without thyroid stimulation. Rhodiola does not belong to the nightshade family and does not increase thyroid hormone production.
This makes it the appropriate ashwagandha substitute for Hashimoto's patients whose main concern is stress-driven symptom worsening.
Vitamin D — Grade B
The VITAL trial (2022) demonstrated a 22% reduction in autoimmune disease incidence with vitamin D3 2,000 IU daily. Most integrative practitioners target serum 25(OH)D of 40–60 ng/mL for autoimmune thyroid disease. Vitamin D modulates regulatory T cells and may reduce the autoimmune attack that ashwagandha could inadvertently amplify.
For a comprehensive ranking, see our complete Hashimoto's supplement guide.
How to Trial Ashwagandha Safely
If you have determined — with your doctor — that you are in a population where ashwagandha is appropriate, follow this protocol to minimize risk.
Step 1: Baseline Labs
Before your first dose, get a complete thyroid panel:
- TSH — your pituitary's signal to the thyroid
- Free T4 — the primary thyroid hormone (inactive form)
- Free T3 — the biologically active thyroid hormone
- TPO antibodies — to confirm or rule out Hashimoto's
- Thyroglobulin antibodies — secondary autoimmune marker
- Cortisol (morning, fasting) — if stress reduction is your goal
Record these numbers. You need them for comparison at 8 weeks.
Step 2: Choose Your Extract and Dose
- Non-autoimmune subclinical hypothyroidism: 600mg/day KSM-66
- Stress/cortisol focus: 300mg KSM-66 twice daily
- Hashimoto's in remission (doctor-supervised): 300mg KSM-66 once daily
Step 3: Monitor for 8 Weeks
Track these symptoms weekly:
Stop immediately if you develop:
- Heart palpitations or rapid heartbeat
- Tremor in your hands
- Increased anxiety or insomnia beyond baseline
- Unexplained weight loss
- Heat intolerance
- Diarrhea
Positive signs to note:
- Improved energy and reduced fatigue
- Better stress tolerance
- Improved mood and cognitive clarity
- Reduced cold intolerance
Step 4: Retest at 8 Weeks
Repeat the same thyroid panel. Compare:
- TSH should have decreased toward the optimal range (1.0–2.5 mIU/L for most patients)
- Free T4 and free T3 should have increased but not exceeded the upper reference range
- TPO antibodies should not have increased — any significant rise suggests the immune system is reacting negatively
- Cortisol should have decreased if stress was your primary indication
Step 5: Decide
- Labs improved, no adverse symptoms → continue at current dose, retest every 3–6 months
- Labs unchanged, no adverse symptoms → may increase dose (if not already at 600mg) or discontinue
- TPO antibodies increased or hyperthyroid symptoms appeared → stop ashwagandha, retest in 4–6 weeks, consider selenium and myo-inositol instead
- Any adverse symptoms regardless of labs → stop and consult your provider
Frequently Asked Questions
Is ashwagandha safe for Hashimoto's?
It depends on disease activity. Ashwagandha stimulates thyroid hormone production and has immune-modulating properties. For Hashimoto's patients with high TPO antibodies or active autoimmune flares, ashwagandha may worsen the condition. Patients in remission with low antibodies may tolerate it under medical supervision, but selenium, myo-inositol, and rhodiola are safer first-line options.
Does ashwagandha increase thyroid hormones?
Yes. The Sharma et al. 2018 RCT showed significant increases in T3 and T4 and a decrease in TSH in subclinical hypothyroidism at 600mg/day over 8 weeks. This is beneficial for non-autoimmune hypothyroidism but creates risk for Hashimoto's.
Can ashwagandha cause hyperthyroidism?
Yes — multiple case reports document ashwagandha-induced thyrotoxicosis (Kamal et al. 2022, van der Hooft et al. 2005). Hashimoto's patients are especially vulnerable due to hashitoxicosis cycling between hypo- and hyperthyroid states.
Is ashwagandha a nightshade?
Yes. Withania somnifera belongs to the Solanaceae family. It is eliminated on the AIP diet. If you are nightshade-sensitive, avoid ashwagandha and use rhodiola rosea for stress support instead.
What is the best ashwagandha dosage for thyroid?
The studied dose is 600mg/day of standardized root extract (KSM-66 or equivalent, ≥5% withanolides). For stress reduction, 300mg KSM-66 twice daily. For Hashimoto's patients attempting a cautious trial, start at 300mg once daily.
What are better alternatives to ashwagandha for Hashimoto's?
Selenium (200mcg, Grade A), myo-inositol (600mg + selenium, Grade B), rhodiola rosea (200–400mg, Grade B for stress), and vitamin D (2,000–4,000 IU, Grade B) all have stronger evidence in Hashimoto's and do not carry thyroid-stimulating risks.
How long should I trial ashwagandha before retesting?
Eight weeks, based on the Sharma 2018 RCT protocol. Get a full thyroid panel before starting and at 8 weeks. Stop sooner if hyperthyroid symptoms (palpitations, tremor, anxiety, weight loss) develop.
Can I take ashwagandha with levothyroxine?
Only under medical supervision. Ashwagandha increases endogenous thyroid hormone production, which may compound with levothyroxine. Separate doses by 4+ hours and monitor thyroid labs every 4–6 weeks initially.
The Bottom Line
Ashwagandha is a genuinely effective thyroid-supporting supplement — for the right patient. The Sharma 2018 RCT provides Grade B evidence for subclinical hypothyroidism without an autoimmune component. The cortisol-lowering evidence (Chandrasekhar 2012) is Grade B for stress-related thyroid dysfunction.
For Hashimoto's patients, the calculation is different. There is no RCT evidence in this population. The mechanism of action (thyroid stimulation + immune modulation) creates plausible risks in a gland under autoimmune attack. Case reports of thyrotoxicosis confirm the risk is not theoretical. And ashwagandha is a nightshade, eliminated on the protocol that many Hashimoto's patients follow.
The evidence-based approach for Hashimoto's patients:
- Confirm your diagnosis — get TPO and Tg antibodies tested
- Start with proven Hashimoto's interventions — selenium, myo-inositol, vitamin D, AIP diet
- Address stress with rhodiola if cortisol is your primary concern — it does not stimulate the thyroid
- Consider ashwagandha only in remission — low antibodies, stable labs, under medical supervision, with the 8-week trial protocol above
Not sure which interventions are right for your condition? Take the free AutoimmuneFinder quiz — it generates a personalized, evidence-graded protocol based on your specific diagnosis, labs, and symptoms.
This article is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting any supplement, especially if you have an autoimmune thyroid condition or take thyroid medication.